Certain Ordinary Shares of Kindstar Globalgene Technology, Inc. are subject to a Lock-Up Agreement Ending on 15-JAN-2022. These Ordinary Shares will be under lockup for 185 days starting from 14-JUL-2021 to 15-JAN-2022.

Details:
Each of the Dr. Huang, Ms. Guo and Perfect Tactic (collectively, the “Major Shareholders”) and existing shareholders has undertaken to each of company, the Joint Global Coordinators, the Joint Bookrunners, the Hong Kong Underwriters and the Joint Sponsors that, it will not, at any time during the First Six-Month Period from the listing date they'll not, (i) sell, offer to sell, contract or agree to sell, create any short position, mortgage, charge, pledge, hypothecate, lend, grant or sell any option, warrant, contract or right to purchase, grant or purchase any option, warrant, contract or right to sell, or otherwise transfer or dispose of or create an Encumbrance over, or agree to transfer or dispose of or create an encumbrance over, either directly or indirectly, conditionally or unconditionally, any Shares or other securities of Company or any interest therein (including any securities convertible into or exchangeable or exercisable for or that represent the right to receive, or any warrants or other rights to purchase, any Shares), or deposit any Shares or other securities of Company with a depositary in connection with the issue of depositary receipts, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares or other securities of Company or any interest therein (including any securities convertible into or exchangeable or exercisable for or that represent the right to receive, or any warrants or other rights to purchase, any Shares or such other securities, as applicable or any interest in any of the foregoing).

The shares shareholders will be subject to a lock-up of further six months from the expiry of first lock-up period and will take all reasonable steps to ensure that it will not create a disorderly or false market in the securities of Company.